Skip to main content
RGC logo

RGC · Regencell Bioscience Holdings Ltd

$5.65 -0.32 (-5.36%) At close · Jul 29
Market Cap
$2.79B
Shares
494.49M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Net Income
-$3.58M +16.7%
FY2025 Net Income FY2021–FY2025
Diluted EPS
-$0.72 -8190.9%
FY2025 Diluted EPS FY2022–FY2025
Operating Cash Flow
-$3.11M +22.2%
FY2025 Operating Cash Flow FY2021–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024 FY2023 FY2022 FY2021
$948.29K $1.07M $1.58M $2.51M $438.32K
$8014 $125.43K $262.66K $25.28K $1576
$2.81M $3.55M $4.43M $5.08M $941.46K
$454.25K
$3.77M $4.74M $6.27M $7.62M $1.38M
-$3.77M -$4.74M -$6.27M -$7.62M -$1.38M
$185.77K $248K $85.4K
-$3.58M -$4.36M -$6.06M -$7.59M -$1.35M
-$3.58M -$4.3M -$5.87M -$7.59M -$1.35M
-$61.38K -$61.38K -$191.2K $1.35M
-$5.96M $7.45M
-$3.6M -$4.32M -$6.15M -$7.59M -$1.35M
USD/shares -$0.72 -$0.01 $0.01 $0.02
USD/shares -$0.72 -$0.01 -$0.01 -$0.02
shares 494.49M 494.49M 494.49M 486.62M 4.94
shares 494.49M 494.49M 494.49M 486.62M 380M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Segment Operating Income

Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.

By Segment (USD)

Component FY2025 FY2024 FY2023
Segment -$3,769,985 -$4,736,726 -$6,273,671
Key facts CIK 1829667 CUSIP G7487R100 13F (30d) 3 filings 3 filers Visit website